With me on the call today are Joshua B. Cohen and Justin B. Klee, our Co-CEOs; Dr. Camille L. Bedrosian, our Chief Medical ...

Our team is prepared to resubmit the upitigramab BLA following a successful FDA reinspection of the Catalent, Indiana ...

Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...

This useful study supplements previous publications of willed attention by addressing a frontoparietal network that supports internal goal generation. The evidence is solid in analyzing two datasets ...

Jay Olson Oppenheimer & Co. Inc., Research Division. Hello, everyone, and welcome to Oppenheimer's 36th Annual Life Science Conference. I'm Jay Olson, one of the biotech analysts ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.